Viral Lymphoma

1:47
Oral nanatinostat and valganciclovir for EBV-associated lymphomas
Pierluigi Porcu
2:36
Dutch HOVON lymphoma study group update
Pieternella Lugtenburg
8:24
Viral lymphomas: risk factors and treatments
Catherine Bollard et al.
9:57
Cellular therapy and drug access for viral lymphomas
Catherine Bollard et al.
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals